<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ksma</journal-id><journal-title-group><journal-title xml:lang="ru">Кубанский научный медицинский вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Kuban Scientific Medical Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1608-6228</issn><issn pub-type="epub">2541-9544</issn><publisher><publisher-name>Kuban State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">ksma-154</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>АЛГОРИТМ ПАТОГЕНЕТИЧЕСКОЙ ДИАГНОСТИКИ ТРОМБОЦИТОПЕНИИ</article-title><trans-title-group xml:lang="en"><trans-title>SEARCHING ALGORITHM OF CAUSES OF THROMBOCYTOPENIA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пашкова</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pashkova</surname><given-names>I. A.</given-names></name></name-alternatives><email xlink:type="simple">irpash@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гилевич</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gilevich</surname><given-names>I. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Минеева</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mineeva</surname><given-names>N. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ «Краевая клиническая больница № 1 им. С.В. Очаповского» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnodar regional hospital № 1</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>01</day><month>06</month><year>2014</year></pub-date><issue>3</issue><fpage>93</fpage><lpage>99</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пашкова И.А., Гилевич И.В., Минеева Н.В., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Пашкова И.А., Гилевич И.В., Минеева Н.В.</copyright-holder><copyright-holder xml:lang="en">Pashkova I.A., Gilevich I.V., Mineeva N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ksma.elpub.ru/jour/article/view/154">https://ksma.elpub.ru/jour/article/view/154</self-uri><abstract><p>В практике врача часто приходится наблюдать пациентов с тромбоцитопенией, когда требуется решать вопрос о необходимости трансфузии тромбоконцентрата. Однако генез снижения содержания тромбоцитов не всегда очевиден, что требует уточнения причин возникновения тромбоцитопении. В данной статье мы осветили основные патогенетические варианты развития тромбоцитопении. Нами представлен алгоритм, который поможет практикующему врачу разобраться с причинами тромбоцитопении и определить при необходимости трансфузионную тактику пациента, так как решение о переливании тромбоцитов зависит как от клинической ситуации, так и от вида тромбоцитопении. Абсолютными показаниями для трансфузии тромбоцитов являются оперативные вмешательства и угрожающие жизни кровотечения, в то время как к относительным показаниям относится тромбоцитопения потребления.</p></abstract><trans-abstract xml:lang="en"><p>In practice are often observed patients with thrombocytopenia requiring the correction by transfusion of platelet. However, the cause of the platelet's reduction is not always obvious, what needs to be clarified. In this article, we described the main pathogenic types of thrombocytopenia. We present an algorithm that will help the physicians to understand the causes of thrombocytopenia and to determine the necessity of platelet transfusions depending on the clinical settings and on the type of thrombocytopenia. Absolute indications for platelet transfusions are surgeries and life-threatening bleeding, while the relative indications are thrombocytopenia due to consumption.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>тромбоцитопения</kwd><kwd>виды тромбоцитопении</kwd><kwd>thrombocytopenia</kwd><kwd>the type of thrombocytopenia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Баркаган З.С. Патология тромбоцитарного гемостаза // Руководство по гематологии. - Москва, 2005. - С. 416.</mixed-citation><mixed-citation xml:lang="en">Баркаган З.С. Патология тромбоцитарного гемостаза // Руководство по гематологии. - Москва, 2005. - С. 416.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Бессмельцев С.С. Идиопатическая тромбоцитопеническая пурпура // Гематология: новейший справочник. - Москва, 2004. - С. 928.</mixed-citation><mixed-citation xml:lang="en">Бессмельцев С.С. Идиопатическая тромбоцитопеническая пурпура // Гематология: новейший справочник. - Москва, 2004. - С. 928.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Мамаев Н.Н. Тромбоцитопении // Гематология: руководство для врачей. - Санкт-Петербург, 2008. - С. 543.</mixed-citation><mixed-citation xml:lang="en">Мамаев Н.Н. Тромбоцитопении // Гематология: руководство для врачей. - Санкт-Петербург, 2008. - С. 543.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Масчан А.А., Румянцев А.Г. Стимуляция продукции тромбоцитов: новый подход к лечению хронической иммунной тромбоцитопенической пурпуры // Онкогематология. - 2009. -№ 1. - С. 51-56.</mixed-citation><mixed-citation xml:lang="en">Масчан А.А., Румянцев А.Г. Стимуляция продукции тромбоцитов: новый подход к лечению хронической иммунной тромбоцитопенической пурпуры // Онкогематология. - 2009. -№ 1. - С. 51-56.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Птушкин В.В., Миненко С.В., Биячуев Э.Р., Пшонкин А.В., Шубина А.В. Лечение больных с резистентной иммунной тромбоцитопенией: обзор литературы и клинические наблюдения // Онкогематология. - 2011. - № 1. - С. 56-63.</mixed-citation><mixed-citation xml:lang="en">Птушкин В.В., Миненко С.В., Биячуев Э.Р., Пшонкин А.В., Шубина А.В. Лечение больных с резистентной иммунной тромбоцитопенией: обзор литературы и клинические наблюдения // Онкогематология. - 2011. - № 1. - С. 56-63.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Филатов Л.Б. Тромботические микроангиопатии // Клиническая онкогематология. - 2008. - № 4. - С. 366-376.</mixed-citation><mixed-citation xml:lang="en">Филатов Л.Б. Тромботические микроангиопатии // Клиническая онкогематология. - 2008. - № 4. - С. 366-376.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Armstrong B. Benefits and risks of transfusion // ISBT science series. - 2008. - Vol. 3. № 2. - P. 216-231.</mixed-citation><mixed-citation xml:lang="en">Armstrong B. Benefits and risks of transfusion // ISBT science series. - 2008. - Vol. 3. № 2. - P. 216-231.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Aster R.H., Curtis B.R., McFarland J.G., Bougie D.W. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management // J. thromb. haemost. - 2009. - Vol. 7. № 6. -P. 911-918.</mixed-citation><mixed-citation xml:lang="en">Aster R.H., Curtis B.R., McFarland J.G., Bougie D.W. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management // J. thromb. haemost. - 2009. - Vol. 7. № 6. -P. 911-918.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Beck O.N. Thrombocytopenia. Chapter 11 // Diagnostic hematology. - London, 2009. - P. 518.</mixed-citation><mixed-citation xml:lang="en">Beck O.N. Thrombocytopenia. Chapter 11 // Diagnostic hematology. - London, 2009. - P. 518.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Cines D.B., Blanchette V.S. Immune thrombocytopenic purpura // Engl. j. med. - 2002. - Vol. 346. № 13. -P. 995-1008.</mixed-citation><mixed-citation xml:lang="en">Cines D.B., Blanchette V.S. Immune thrombocytopenic purpura // Engl. j. med. - 2002. - Vol. 346. № 13. -P. 995-1008.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cortelazzo S., Finazzi G., Buelli M., Molteni A., Viero P., Barbui T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopeniapurpura // Blood. - 1991. - Vol. 77. № 1. - P. 31-33.</mixed-citation><mixed-citation xml:lang="en">Cortelazzo S., Finazzi G., Buelli M., Molteni A., Viero P., Barbui T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopeniapurpura // Blood. - 1991. - Vol. 77. № 1. - P. 31-33.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome // N. engl. j. med. - 1998. - Vol. 339. № 22. -P. 1578-1584.</mixed-citation><mixed-citation xml:lang="en">Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome // N. engl. j. med. - 1998. - Vol. 339. № 22. -P. 1578-1584.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Gauer R.L., Braun M.M. Thrombocytopenia // Am. fam. physician. - 2012. - Vol. 85. № 6. - P. 612-622.</mixed-citation><mixed-citation xml:lang="en">Gauer R.L., Braun M.M. Thrombocytopenia // Am. fam. physician. - 2012. - Vol. 85. № 6. - P. 612-622.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Godeau B., Chevret S., Varet B., Lefrère F., Zini J.M., Bassompierre F., et al. French ATIP Study Group. Intravenous immunoglobulin in high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomized, multicentre trial // Lancet. - 2002. - Vol. 359. № 9300. - P. 23-29.</mixed-citation><mixed-citation xml:lang="en">Godeau B., Chevret S., Varet B., Lefrère F., Zini J.M., Bassompierre F., et al. French ATIP Study Group. Intravenous immunoglobulin in high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomized, multicentre trial // Lancet. - 2002. - Vol. 359. № 9300. - P. 23-29.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hillman R.S., Ault K.A., Rinder H. Thrombocytopenia. Chapter 30 // Hematology in clinical practice: a guide to diagnosis and management. - New York, 2005. - P. 512.</mixed-citation><mixed-citation xml:lang="en">Hillman R.S., Ault K.A., Rinder H. Thrombocytopenia. Chapter 30 // Hematology in clinical practice: a guide to diagnosis and management. - New York, 2005. - P. 512.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kiefel V., Santoso S., Mueller-Eckhardt C. Serological, biochemical, and molecular aspects of platelet autoantigens // Sem. hematol. - 1992. - Vol. 29. № 1. - P. 26-33.</mixed-citation><mixed-citation xml:lang="en">Kiefel V., Santoso S., Mueller-Eckhardt C. Serological, biochemical, and molecular aspects of platelet autoantigens // Sem. hematol. - 1992. - Vol. 29. № 1. - P. 26-33.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lotta L.A., Garagiola I., Palla R., Cairo A., Peyvandi F. ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura // Hum. mutat. - 2010. - Vol. 31. № 1. - P. 11-19.</mixed-citation><mixed-citation xml:lang="en">Lotta L.A., Garagiola I., Palla R., Cairo A., Peyvandi F. ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura // Hum. mutat. - 2010. - Vol. 31. № 1. - P. 11-19.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Provan D., Stasi R., Newland A.C., Blanchette V.S., Bolton-Maggs P., Bussel J.B. International consensus report on the investigation and management of primary immune thrombocytopenia // Blood. - 2010. - Vol. 115. № 2. - P. 168-186.</mixed-citation><mixed-citation xml:lang="en">Provan D., Stasi R., Newland A.C., Blanchette V.S., Bolton-Maggs P., Bussel J.B. International consensus report on the investigation and management of primary immune thrombocytopenia // Blood. - 2010. - Vol. 115. № 2. - P. 168-186.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Puyo C.A. Thrombocytopenia // Inter. anesthesiol. clin. -2001. - Vol. 39. № 1. - P. 17-34.</mixed-citation><mixed-citation xml:lang="en">Puyo C.A. Thrombocytopenia // Inter. anesthesiol. clin. -2001. - Vol. 39. № 1. - P. 17-34.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Schlenke P., Sibrowski W. Cross-sectional guidelines for therapy with blood components and plasma derivatives // Transfus. med. hemotherapy. - 2009. - Vol. 36. № 6. -P. 345-492.</mixed-citation><mixed-citation xml:lang="en">Schlenke P., Sibrowski W. Cross-sectional guidelines for therapy with blood components and plasma derivatives // Transfus. med. hemotherapy. - 2009. - Vol. 36. № 6. -P. 345-492.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Schoonen M., Kucera G., Coalson J., Lin Li, Rutstein M., Mowat F., Fryzek J., Kaye J.A. Epidemiology of immune thrombocytopenic purpura in the general practice research database // Br. j. haematol. - 2009. - Vol. 145. № 2. - P. 235-244.</mixed-citation><mixed-citation xml:lang="en">Schoonen M., Kucera G., Coalson J., Lin Li, Rutstein M., Mowat F., Fryzek J., Kaye J.A. Epidemiology of immune thrombocytopenic purpura in the general practice research database // Br. j. haematol. - 2009. - Vol. 145. № 2. - P. 235-244.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Slichter S.J. Relationship between platelet count and bleeding risk in thrombocytopenic patients // Transfus. med. rev. -2004. - Vol. 18. № 3. - P. 153-167.</mixed-citation><mixed-citation xml:lang="en">Slichter S.J. Relationship between platelet count and bleeding risk in thrombocytopenic patients // Transfus. med. rev. -2004. - Vol. 18. № 3. - P. 153-167.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Terrell D.R., Williams L.A., Vesely S.K., Lämmle B., Hovinga J.A., George J.N. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency // J. thromb. haemost. - 2005. - Vol. 3. № 7. - P. 1432-1436.</mixed-citation><mixed-citation xml:lang="en">Terrell D.R., Williams L.A., Vesely S.K., Lämmle B., Hovinga J.A., George J.N. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency // J. thromb. haemost. - 2005. - Vol. 3. № 7. - P. 1432-1436.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Tsai H.M., Li A., Rock G. Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura // Clin. lab. - 2001. - Vol. 47. № 7. - P. 387-392.</mixed-citation><mixed-citation xml:lang="en">Tsai H.M., Li A., Rock G. Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura // Clin. lab. - 2001. - Vol. 47. № 7. - P. 387-392.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Van den Bemt P.M., Meyboom R.H., Egberts A.C. Drug-induced immune thrombocytopenia // Drug. saf. - 2004. - Vol. 27. № 15. - P. 1243-1252.</mixed-citation><mixed-citation xml:lang="en">Van den Bemt P.M., Meyboom R.H., Egberts A.C. Drug-induced immune thrombocytopenia // Drug. saf. - 2004. - Vol. 27. № 15. - P. 1243-1252.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Veneri D., Franchini M., Randon F., Nichele I., Pizzolo G, Ambrosetti A. Thrombocytopenia: a clinical point of view // Blood transfus. - 2009. - Vol. 7. № 2. - P. 75-85.</mixed-citation><mixed-citation xml:lang="en">Veneri D., Franchini M., Randon F., Nichele I., Pizzolo G, Ambrosetti A. Thrombocytopenia: a clinical point of view // Blood transfus. - 2009. - Vol. 7. № 2. - P. 75-85.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
